Together, these findings show that an elevated GPR55 expression is associated with the highly aggressive basal/triple-negative breast cancer subtype, higher probability to develop metastases, and therefore poor patient prognosis. This evidence concerns the gene GPR55 and triple-negative breast carcinoma.